Click and hold a term momentarily to select items without that term.

Purpose

Treatment Type

7 items
5
μg/mL
functional characterization
false
4
hour
Jesse Engreitz, Stanford
stimulation
released
Treatment of 5 μg/mL T-cell surface glycoprotein CD3 gamma chain for 4 hours
UniProtKB:P09693
T-cell surface glycoprotein CD3 gamma chain
protein
df02c0d4-f796-4f77-bfbc-388cdbfcc615
1
μM
functional characterization
false
6
hour
Jesse Engreitz, Stanford
activation
released
Treatment of 1 μM 5-Phenyl-1H-indole-3-acetic acid for 6 hours
CHEBI:22676
5-Phenyl-1H-indole-3-acetic acid
chemical
d35868d1-c45b-49ae-8ff3-a9c0c22551c2
1
μM
functional characterization
false
3
day
Charles Gersbach, Duke
perturbation
released
Treatment of 1 μM Endothelin-1 for 3 days
CHEBI:80240
Endothelin-1
chemical
bbe5df8d-a9e2-4a99-8942-9b3b7d12c605
functional characterization
true
Jay Shendure, UW
differentiation
released
Depletion of Leukemia inhibitory factor
UniProtKB:P09056
Leukemia inhibitory factor
protein
9acc7857-c9dd-4b4a-a78b-fdf10c8ae679
4
μM
functional characterization
false
7
day
Charles Gersbach, Duke
antagonist
released
Treatment of 4 μM GSK3 inhibition for 7 days
CHEBI:91091
GSK3 inhibition
chemical
98ba0c5c-8005-41bc-bcbb-6c6eff41af4e
100
ng/mL
functional characterization
false
4
hour
Jesse Engreitz, Stanford
stimulation
released
Treatment of 100 ng/mL phorbol 13-acetate 12-myristate for 4 hours
CHEBI:37537
phorbol 13-acetate 12-myristate
chemical
42b3c61d-38de-4bd2-bb39-33c125a417cb
2
μg/mL
functional characterization
false
Jay Shendure, UW
differentiation
released
Treatment of 2 μg/mL doxycycline hyclate
CHEBI:34730
doxycycline hyclate
chemical
13a2bfe2-9124-4254-b0fe-8c221077201f